UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$20.63K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 3, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$490.24
Sep 3, 2026
Close before public filing
$490.24
Sep 3, 2026
Return since public filing
+1.4%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 42 shares @ $491.25
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000135
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$5.91M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 3, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Exercise | Sep 3, 2026 | $69.48K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $95.81K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $211.43K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $288.88K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $192.94K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $38.7K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $116.44K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $200.04K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $697.16K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $783.85K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $1.52M |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $461.07K |
| United Therapeutics Corp UTHR Current | Sale | Sep 3, 2026 | $20.63K |
| United Therapeutics Corp UTHR | Exercise | Sep 3, 2026 | $0 |